Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi · 2010
[Surgery in advanced cervical cancer].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Velenciuc Natalia, Luncă S, Velenciuc I, Pantazescu A
Аннотация
UNLABELLED: The aim of this study was to highlight the importance of surgical treatment in advanced cervical cancer (IIB-IIIB).
MATERIAL AND METHOD: Data from 179 patients with cervical cancer, admitted in the Clinic of Emergency Surgery, "Sf. Ioan" Hospital, Iaşi, between January, 1st, 2003 and December, 31st, 2009, were collected.
RESULTS: A number of 11 cases (6.1%) cases were without any clinical response, so that they benefit by radical radiotherapy; a radical surgical intervention was performed in the other 168 cases (93.7%), in 4-6 weeks after chemotherapy. No intraoperative complications were evidenced, but after surgical intervention we recorded: urinary troubles--10 (6.5%); lymphedema--3 (1.9%); posttoperative intestinal occlusions--2 (1.3%); extended dynamic ileus--2 (1.3%); phlebitis--2 (1.3%).
MATERIAL AND METHOD: Data from 179 patients with cervical cancer, admitted in the Clinic of Emergency Surgery, "Sf. Ioan" Hospital, Iaşi, between January, 1st, 2003 and December, 31st, 2009, were collected.
RESULTS: A number of 11 cases (6.1%) cases were without any clinical response, so that they benefit by radical radiotherapy; a radical surgical intervention was performed in the other 168 cases (93.7%), in 4-6 weeks after chemotherapy. No intraoperative complications were evidenced, but after surgical intervention we recorded: urinary troubles--10 (6.5%); lymphedema--3 (1.9%); posttoperative intestinal occlusions--2 (1.3%); extended dynamic ileus--2 (1.3%); phlebitis--2 (1.3%).
Предметные рубрики MeSH
AdenocarcinomaAdultAgedAged, 80 and overCarcinomaChemotherapy, AdjuvantFemaleHumansHysterectomyIleusIntestinal ObstructionLymphedemaMedical RecordsMiddle AgedNeoplasm StagingPhlebitisRadiotherapy, AdjuvantRetrospective StudiesTreatment FailureTreatment OutcomeUrination DisordersUterine Cervical Neoplasms